Home LiteratureArticle Details
PMID: 14716295 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The EBNA-3 gene family proteins disrupt the G2/M checkpoint.

Oncogene ·Vol. 23 ·No. 7 ·2004-02-19 ·Pages 1342-53

Krauer KG, Burgess A, Buck M, Flanagan J, Sculley TB, Gabrielli B

Abstract

The Epstein-Barr nuclear antigens (EBNA), EBNA-3, -4 and -6, have previously been shown to act as transcriptional regulators, however, this study identifies another function for these proteins, disruption of the G2/M checkpoint. Lymphoblastoid cell lines (LCLs) treated with a G2/M initiating drug azelaic bishydroxamine (ABHA) did not show a G2/M checkpoint response, but rather they display an increase in cell death, a characteristic of sensitivity to the cytotoxic effects of the drug. Cell cycle analysis demonstrated that the individual expression of EBNA-3, -4 or -6 are capable of disrupting the G2/M checkpoint response induced by ABHA resulting in increased toxicity, whereas EBNA-2, and -5 were not. EBNA-3 gene family protein expression also disrupted the G2/M checkpoint initiated in response to the genotoxin etoposide and the S phase inhibitor hydroxyurea. The G2 arrest in response to these drugs were sensitive to caffeine, suggesting that ATM/ATR signalling in these checkpoint responses may be blocked by the EBNA-3 family proteins. The function of EBNA-3, -4 and -6 proteins appears to be more complex than anticipated and these data suggest a role for these proteins in disrupting the host cell cycle machinery.

MeSH Terms
Ataxia Telangiectasia Mutated Proteins Cell Cycle Proteins Checkpoint Kinase 2 DNA Damage/physiology DNA-Binding Proteins Epstein-Barr Virus Nuclear Antigens/immunology,metabolism G2 Phase/drug effects,physiology Histone Deacetylase Inhibitors Humans Hydroxamic Acids/pharmacology Mitosis/drug effects,physiology Precipitin Tests Protein Serine-Threonine Kinases/immunology,metabolism Signal Transduction/physiology Tumor Suppressor Proteins
Chemicals
Cell Cycle Proteins DNA-Binding Proteins Epstein-Barr Virus Nuclear Antigens Histone Deacetylase Inhibitors Hydroxamic Acids Tumor Suppressor Proteins azelaic bishydroxamic acid Checkpoint Kinase 2 ATM protein, human ATR protein, human Ataxia Telangiectasia Mutated Proteins CHEK2 protein, human Protein Serine-Threonine Kinases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Krauer Kenia G
Queensland Institute of Medical Research and Joint Oncology Program, University of Queensland, Brisbane, Australia. keniaK@qimr.edu.au
Burgess Andrew
Buck Marion
Flanagan James
Sculley Tom B
Gabrielli Brian
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
2004-02-19
Pages
1342-53
Language
English
Region
England
NLM ID
8711562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com